Characterization of Spherulites As a Lipidic Carrier for Low and High Molecular Weight Agents

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2013 Apr 13

PMID 23579481

Citations 2

Authors

Peng Zhang

Yixian Huang

Alexander M Makhov

Xiang Gao

Peijun Zhang

Song Li

Affiliations

Soon will be listed here.

Abstract

Purpose: To develop spherulite formulations to achieve high entrapment efficiency for both small and macromolecules as well as cell-type specific delivery.

Methods: Spherulites of various compositions were prepared, and lipid-PEG was incorporated through post-insertion. Calcein and FITC-labeled albumin were employed as model drugs for small and macromolecules. The spherulites were characterized with respect to entrapment efficiency, size, structure, and release kinetics, and the morphology was examined via cryo-EM. Finally, SV119-decorated spherulites were examined for their selective uptake by cancer cells.

Results: The spherulites are 170 ~ 290 nm in size. A loading efficiency of 55 ~ 60% can be consistently achieved for both calcein and albumin under optimized conditions. Cryo-EM shows the onion-like morphology consistent with the structure of multilamellar liposomes. A t(½) of 39.3 h and 69.7 h in cargo release in serum was observed before and after PEG decoration, and incorporation of SV119 led to selective delivery of rhodamine-labeled spherulites to PC-3 tumor cells.

Conclusions: Our optimized formulations may represent a platform with simple preparation approach, relatively small particle size, high drug loading efficiency for both low and high molecular weight agents, and slow release kinetics for selective delivery of various types of therapeutics to target cells.

Citing Articles

Engineering Lipid Spherulites for the Sustained Release of Highly Dosed Small Hydrophilic Compounds.

Montanari E, Krupke H, Leroux J Adv Healthc Mater. 2022; 12(10):e2202249.

PMID: 36571233 PMC: 11469156. DOI: 10.1002/adhm.202202249.

Cryo-EM sample preparation method for extremely low concentration liposomes.

Tonggu L, Wang L Ultramicroscopy. 2019; 208:112849.

PMID: 31622807 PMC: 7058178. DOI: 10.1016/j.ultramic.2019.112849.

References

Nikolova A, Jones M . Effect of grafted PEG-2000 on the size and permeability of vesicles. Biochim Biophys Acta. 1996; 1304(2):120-8. DOI: 10.1016/s0005-2760(96)00112-9. View

Torchilin V . Multifunctional nanocarriers. Adv Drug Deliv Rev. 2006; 58(14):1532-55. DOI: 10.1016/j.addr.2006.09.009. View

Kim M, Kim J, Lee H, Kim J, Yang J . Release property of temperature-sensitive alginate beads containing poly(N-isopropylacrylamide). Colloids Surf B Biointerfaces. 2005; 46(1):57-61. DOI: 10.1016/j.colsurfb.2005.09.002. View

Demel R, Kinsky S, Kinsky C, Van Deenen L . Effects of temperature and cholesterol on the glucose permeability of liposomes prepared with natural and synthetic lecithins. Biochim Biophys Acta. 1968; 150(4):655-65. DOI: 10.1016/0005-2736(68)90055-2. View

Torchilin V . Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 2006; 24(1):1-16. DOI: 10.1007/s11095-006-9132-0. View

Simard P, Hoarau D, Khalid M, Roux E, Leroux J . Preparation and in vivo evaluation of PEGylated spherulite formulations. Biochim Biophys Acta. 2005; 1715(1):37-48. DOI: 10.1016/j.bbamem.2005.06.013. View

Lian T, Ho R . Trends and developments in liposome drug delivery systems. J Pharm Sci. 2001; 90(6):667-80. DOI: 10.1002/jps.1023. View

Maeda H, Wu J, Sawa T, Matsumura Y, Hori K . Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000; 65(1-2):271-84. DOI: 10.1016/s0168-3659(99)00248-5. View

Zhang Y, Huang Y, Zhang P, Gao X, Gibbs R, Li S . Incorporation of a selective sigma-2 receptor ligand enhances uptake of liposomes by multiple cancer cells. Int J Nanomedicine. 2012; 7:4473-85. PMC: 3422102. DOI: 10.2147/IJN.S31981. View

10.

Blume G, Cevc G . Liposomes for the sustained drug release in vivo. Biochim Biophys Acta. 1990; 1029(1):91-7. DOI: 10.1016/0005-2736(90)90440-y. View

11.

Colabufo N, Berardi F, Contino M, Ferorelli S, Niso M, Perrone R . Correlation between sigma2 receptor protein expression and histopathologic grade in human bladder cancer. Cancer Lett. 2005; 237(1):83-8. DOI: 10.1016/j.canlet.2005.05.027. View

12.

Mignet N, Brun A, Degert C, Delord B, Roux D, Helene C . The spherulites(TM): a promising carrier for oligonucleotide delivery. Nucleic Acids Res. 2000; 28(16):3134-42. PMC: 108452. DOI: 10.1093/nar/28.16.3134. View

13.

Redkar M, Hassan P, Aswal V, Devarajan P . Onion phases of PEG-8 distearate. J Pharm Sci. 2007; 96(9):2436-45. DOI: 10.1002/jps.20863. View

14.

Mach R, Smith C, Whirrett B, Childers S, Wheeler K . Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res. 1997; 57(1):156-61. View

15.

Torchilin V . Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev. 2010; 63(3):131-5. DOI: 10.1016/j.addr.2010.03.011. View

16.

Haran G, Cohen R, Bar L, Barenholz Y . Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim Biophys Acta. 1993; 1151(2):201-15. DOI: 10.1016/0005-2736(93)90105-9. View

17.

Kashiwagi H, McDunn J, Simon Jr P, Goedegebuure P, Xu J, Jones L . Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy. Mol Cancer. 2007; 6:48. PMC: 1939854. DOI: 10.1186/1476-4598-6-48. View

18.

Bangham A, HORNE R . NEGATIVE STAINING OF PHOSPHOLIPIDS AND THEIR STRUCTURAL MODIFICATION BY SURFACE-ACTIVE AGENTS AS OBSERVED IN THE ELECTRON MICROSCOPE. J Mol Biol. 1964; 8:660-8. DOI: 10.1016/s0022-2836(64)80115-7. View

19.

Fonseca M, Jagtenberg J, Haisma H, Storm G . Liposome-mediated targeting of enzymes to cancer cells for site-specific activation of prodrugs: comparison with the corresponding antibody-enzyme conjugate. Pharm Res. 2003; 20(3):423-8. DOI: 10.1023/a:1022608321861. View

20.

Szoka Jr F, Papahadjopoulos D . Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu Rev Biophys Bioeng. 1980; 9:467-508. DOI: 10.1146/annurev.bb.09.060180.002343. View